Showing results (121-130 of 174) with videos related to
Sort By:
Pageof 18
Acta Obstetricia Et Gynecologica Scandinavica|January 19, 2020
CA-125 reduction during neoadjuvant chemotherapy is associated with success of cytoreductive surgery and outcome of patients with advanced high-grade ovarian cancerRoy Kessous, Michel D Wissing, Sabrina Piedimonte, et al.Journal of Minimally Invasive Gynecology|November 29, 2020
Endometrial Cancer in Germline BRCA Mutation Carriers: A Systematic Review and Meta-analysisEmad Matanes, Alexander Volodarsky-Perel, Neta Eisenberg, et al.Gynecologic Oncology Reports|August 17, 2021
Scalp cooling for reducing alopecia in gynecology oncology patients treated with dose-dense chemotherapy: A pilot projectCristina Mitric, Brian How, Emad Matanes, et al.Cancers|April 26, 2025
Examining the Association of Body Mass Index and Complications When Including Sentinel Lymph Node Biopsy in Minimally Invasive Surgery for Endometrial Intraepithelial NeoplasiaGabriel Levin, Pedro T Ramirez, Jason D Wright, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 15, 2013
Vaginal vault dehiscence after robotic hysterectomy for gynecologic cancers: search for risk factors and literature reviewLaura Drudi, Joshua Z Press, Susie Lau, et al.Gynecologic Oncology|April 15, 2015
Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancerJ How, W H Gotlieb, J Z Press, et al.The Lancet. Oncology|December 24, 2011
Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled studyWalter H Gotlieb, Frederic Amant, Suresh Advani, et al.Gynecologic Oncology|November 15, 2016
Minimizing pain medication use and its associated costs following robotic surgeryJeremie Abitbol, Rebecca Cohn, Sandra Hunter, et al.International Journal of Cancer|June 15, 2019
Lifetime recreational moderate-to-vigorous physical activity and ovarian cancer risk: A case-control studyAnne Grundy, Vikki Ho, Michal Abrahamowicz, et al.International Journal of Cancer|November 16, 2020
Multiple lines of chemotherapy for patients with high-grade ovarian cancer: Predictors for response and effect on survivalRoy Kessous, Michel D Wissing, Ido Laskov, et al.Pageof 18